2674-0826

Frontiers in Ophthalmology

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 503 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact503 DOIs
2

Add abstracts to 45 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact45 DOIs
3

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact20 DOIs

DOIs for this ISSN

Showing the top 5 of 503 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Grand Challenges in Ocular Inflammatory Diseases (10.3389/fopht.2022.756689)
Abstract ORCID
58.80 14
2 The spaceflight contrast sensitivity hypothesis and its role… (10.3389/fopht.2023.1229748)
Abstract ORCID
57.31 13
3 On and off signaling pathways in the retina and the visual s… (10.3389/fopht.2022.989002)
ORCID
45.32 64
4 Ophthalmology and Artificial Intelligence: Present or Future… (10.3389/fopht.2022.898181)
Abstract ORCID
38.91 5
5 Optical coherence tomography and optical coherence tomograph… (10.3389/fopht.2023.1217125)
ORCID
37.96 32
6 Editorial: Retinal metabolism in health and disease (10.3389/fopht.2024.1459318)
Abstract References ORCID
35.78 2
7 Correction: The role of IL-6 in thyroid eye disease: an upda… (10.3389/fopht.2025.1641164)
Abstract References ORCID
35.78 2
8 Leber’s hereditary optic neuropathy: Update on current diagn… (10.3389/fopht.2022.1077395)
ORCID
34.95 24
9 Photobiomodulation use in ophthalmology – an overview of tra… (10.3389/fopht.2024.1388602)
ORCID
34.51 23
10 Lysolipids are prominent in subretinal drusenoid deposits, a… (10.3389/fopht.2023.1258734)
ORCID
34.04 22
11 Molecular mechanisms of TGFβ-mediated EMT of retinal pigment… (10.3389/fopht.2022.1060087)
ORCID
33.56 21
12 Initial experiences of switching to faricimab for neovascula… (10.3389/fopht.2023.1346322)
ORCID
33.06 20
13 Effects of Netarsudil-Family Rho Kinase Inhibitors on Human… (10.3389/fopht.2022.948397)
ORCID
32.53 19
14 Glaucoma and microglia-induced neuroinflammation (10.3389/fopht.2023.1132011)
ORCID
32.53 19
15 CAR-Treg cell therapies and their future potential in treati… (10.3389/fopht.2023.1184937)
ORCID
32.53 19
16 Gene therapy for inherited retinal diseases: exploiting new… (10.3389/fopht.2023.1270561)
ORCID
32.53 19
17 Geographic atrophy: pathophysiology and current therapeutic… (10.3389/fopht.2023.1327883)
ORCID
32.53 19
18 UV light and the ocular lens: a review of exposure models an… (10.3389/fopht.2024.1414483)
ORCID
32.53 19
19 Contact Lens Associated Bacterial Keratitis: Common Organism… (10.3389/fopht.2021.759271)
ORCID
31.97 18
20 Utility of artificial intelligence in the diagnosis and mana… (10.3389/fopht.2024.1380701)
ORCID
31.97 18
21 Multidimensional immunotherapy for dry eye disease: current… (10.3389/fopht.2024.1449283)
ORCID
31.97 18
22 Update on ocular manifestations of the main monogenic and po… (10.3389/fopht.2024.1337329)
ORCID
31.38 17
23 Evaluating the strengths and limitations of multimodal ChatG… (10.3389/fopht.2024.1387190)
ORCID
31.38 17
24 Current understanding on Retinitis Pigmentosa: a literature… (10.3389/fopht.2025.1600283)
ORCID
31.38 17
25 Flavoprotein fluorescence elevation is a marker of mitochond… (10.3389/fopht.2023.1110501)
ORCID
30.76 16
26 Neuro-ophthalmic complications of immune checkpoint inhibito… (10.3389/fopht.2022.1044904)
ORCID
30.10 15
27 Non-Arteritic Anterior Ischemic Optic Neuropathy: Challenges… (10.3389/fopht.2022.848710)
Abstract ORCID
30.10 3
28 Glial metabolic alterations during glaucoma pathogenesis (10.3389/fopht.2023.1290465)
ORCID
30.10 15
29 Should we reconsider first-line treatments for glaucoma in t… (10.3389/fopht.2023.958955)
Abstract ORCID
30.10 3
30 Intensity-based optoretinography reveals sub-clinical defici… (10.3389/fopht.2024.1373549)
ORCID
30.10 15
31 Update on non-infectious uveitis treatment: anti-TNF-alpha a… (10.3389/fopht.2024.1412930)
ORCID
30.10 15
32 Iodine contrast should be avoided in patients with thyroid e… (10.3389/fopht.2024.1478805)
Abstract ORCID
30.10 3
33 Improved Ophthalmic Outcomes Following Venous Sinus Stenting… (10.3389/fopht.2022.910524)
ORCID
29.40 14
34 Current surgical techniques for the management of pediatric… (10.3389/fopht.2023.1101281)
ORCID
29.40 14
35 Incidence, risk factors and ophthalmic clinical characterist… (10.3389/fopht.2023.1152215)
ORCID
29.40 14
36 Rod photoreceptor-specific deletion of cytosolic aspartate a… (10.3389/fopht.2023.1306019)
ORCID
29.40 14
37 Diabetes mellitus associated neurovascular lesions in the re… (10.3389/fopht.2022.1012804)
ORCID
28.65 13
38 Bidirectional Effect of IFN-γ on Th17 Responses in Experimen… (10.3389/fopht.2022.831084)
ORCID
28.65 13
39 Toll-Like Receptor Signalling Pathways and the Pathogenesis… (10.3389/fopht.2022.850394)
ORCID
28.65 13
40 Astrocytes of the eye and optic nerve: heterogeneous populat… (10.3389/fopht.2023.1217137)
ORCID
28.65 13
41 ChatGPT: is it good for our glaucoma patients? (10.3389/fopht.2023.1260415)
ORCID
28.65 13
42 Transverse Sinus Stenting Reverses Medically Refractory Idio… (10.3389/fopht.2022.885583)
ORCID
27.85 12
43 Genetics of strabismus (10.3389/fopht.2023.1233866)
ORCID
27.85 12
44 Role of integrins in the development of fibrosis in the trab… (10.3389/fopht.2023.1274797)
ORCID
27.85 12
45 Unlocking the role of lactate: metabolic pathways, signaling… (10.3389/fopht.2023.1296624)
ORCID
27.85 12
46 Advances in the management of intraocular foreign bodies (10.3389/fopht.2024.1422466)
ORCID
27.85 12
47 Proposing a Neurotropic Etiology for Acute Posterior Multifo… (10.3389/fopht.2021.802962)
ORCID
26.98 11
48 Immune Privilege Furnishes a Niche for Latent Infection (10.3389/fopht.2022.869046)
ORCID
26.98 11
49 Regulatory T Cells: Therapeutic Opportunities in Uveitis (10.3389/fopht.2022.901144)
ORCID
26.98 11
50 Deep learning and optical coherence tomography in glaucoma:… (10.3389/fopht.2022.937205)
ORCID
26.98 11